Is MLBON.PA stock a buy after the intraday drop?

MLBON.PA stock at **€4.90** shows a possible short-term oversold bounce, but low liquidity and negative EPS make it a tactical trade rather than a clear buy. Use small position sizes and volume-confirmed entry.

What is Meyka AI's forecast for MLBON.PA stock?

Meyka AI's forecast model projects a 1-year target of **€11.78**, implying **140.82%** upside versus **€4.90**. Forecasts are model-based projections and not guarantees.

What are the main risks when trading MLBON.PA stock intraday?

Primary risks are extremely low liquidity (today's volume **2**), wide spreads, negative profitability, and long receivable days. Stops can fail when volumes stay below average.

How does MLBON.PA stock compare to the Healthcare sector?

MLBON.PA trades at PB **1.09** versus Healthcare average PB **2.06**, showing a book-value discount but weaker margins and higher operational risk compared with sector peers.

EU Stocks

€4.90 low for MLBON.PA bonyf N.V. EURONEXT 21 Jan 2026: Oversold bounce trade idea

ByDanny Kontos January 21, 2026

MLBON.PA stock trades at €4.90 intraday on EURONEXT on 21 Jan 2026, sitting at the year low and showing signs of an oversold bounce setup. Volume is extremely light at 2 shares today versus an average volume of 3, which raises execution risk even as the price sits well below the 50-day average (€9.86) and 200-day average (€12.99). For short-term traders we see a potential technical bounce play, but low liquidity and negative EPS (-1.77) demand strict risk controls and tight sizing.